Congenital Abnormalities: all 781 studies
Page 6 of 8. Open to participants first (77), then studies with results posted, then the rest; newest registration first within each.
- Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT01174888Phase 1
- Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based TherapyCompletedNCT01169363
- Discovering LaryngomalaciaCompletedNCT01165489
- Bupropion and Specific Cardiovascular MalformationsCompletedNCT01165255
- Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic CancerCompletedNCT01164709Phase 1
- Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaTerminatedNCT01159301Phase 1
- Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01154439Phase 1
- Drug Biomarkers in Cell Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01150058
- Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01127009Phase 1
- Vascular Malformations and Abnormalities of GrowthCompletedNCT01105676Not applicable
- Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWithdrawnNCT01101412Phase 1/2
- Developmental Delay in Children Exposed During Pregnancy to Either Lamotrigine,Sodium Valproate, or CarbamazepineStatus unknownNCT01097720
- OTIS Humira Pregnancy RegistryCompletedNCT01086059
- Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantTerminatedNCT01077440
- S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid LeukemiaCompletedNCT01059734
- High-Field MRI Characterization of Wrist and Hand Cartilage Abnormalities in Inflammatory and Chronic RheumatismsCompletedNCT01058161Not applicable
- Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01057095
- Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid MalignanciesCompletedNCT01056614Phase 2
- Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT)CompletedNCT01055327
- Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01031368Phase 1
- Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in RemissionCompletedNCT01020734Phase 2
- Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720CompletedNCT01004965
- Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body IrradiationTerminatedNCT00996359Phase 1
- S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersCompletedNCT00996047
- Vasti Control of Patellofemoral Kinematics in Asymptomatic VolunteerCompletedNCT00978003
- Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell TransplantCompletedNCT00964821
- Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete RemissionCompletedNCT00963521Phase 1
- Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantTerminatedNCT00957736
- Quality of Life in Younger Leukemia and Lymphoma SurvivorsCompletedNCT00956475
- Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersTerminatedNCT00952185Not applicable
- A Standardized Nursing Intervention Protocol for HCT PatientsCompletedNCT00951626Not applicable
- Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for CancerTerminatedNCT00949052
- Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic SyndromeTerminatedNCT00946283Not applicable
- Intensive Glycemic Control on Infectious Morbidity In Patients With Acute LeukemiaWithdrawnNCT00943709Phase 3
- Fetal Anomalies Scan at the Time of Nuchal Translucency StudyStatus unknownNCT00943189
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerActive, not recruitingNCT00935090
- S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic CancerCompletedNCT00919425
- Genetic Modifiers for 22q11.2 SyndromeCompletedNCT00916955
- Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialTerminatedNCT00904514
- Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid LeukemiaCompletedNCT00900380
- Studying Tissue and Blood Samples From Patients With Acute Myeloid LeukemiaActive, not recruitingNCT00900224
- Collecting and Storing Blood Samples From Patients With CancerWithdrawnNCT00900120
- Blood Samples From Patients on a Clinical Trial to CINV During HSCTTerminatedNCT00900068
- Studying Fentanyl in Patients With CancerTerminatedNCT00899951
- Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy VolunteersCompletedNCT00899795
- S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid LeukemiaCompletedNCT00899743
- S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid LeukemiaCompletedNCT00899171
- Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWithdrawnNCT00898612
- Multidrug Resistance Genes in Patients With Acute Myeloid LeukemiaActive, not recruitingNCT00898456
- DNA Analysis of Tumor Tissue From Patients With Acute Myeloid LeukemiaCompletedNCT00897936
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical TrialCompletedNCT00897767
- Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2CompletedNCT00896701
- Non-Invasive Determination of Fetal Chromosome AbnormalitiesStatus unknownNCT00891852
- Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyCompletedNCT00891137Phase 1
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialCompletedNCT00890435
- DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or LymphomaCompletedNCT00889408Phase 1
- Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaCompletedNCT00844441Not applicable
- Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00840684Phase 1/2
- Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk MyelodysplasiaStatus unknownNCT00838240Phase 1/2
- Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerCompletedNCT00823524Phase 1/2
- Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological CancerWithdrawnNCT00816413Phase 1/2
- Telemedicine Consultation in Trauma and OrthopedicCompletedNCT00815243Not applicable
- Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other DiseasesTerminatedNCT00813501
- Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerCompletedNCT00806767Phase 2
- Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to TreatmentTerminatedNCT00800150Phase 1
- Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsCompletedNCT00799461Phase 3
- Middle and Inner Ear Malformation in Children With Velocardiofacial SyndromeCompletedNCT00784173
- Autologous Fat Grafting to the BreastStatus unknownNCT00775788Not applicable
- Perceptions of Burden in Patients With Late-Stage Cancer and Their CaregiversWithdrawnNCT00770419
- Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsStatus unknownNCT00769613Phase 1
- Clinical and Genetic Studies of VACTERL AssociationCompletedNCT00766571
- Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialCompletedNCT00750009Phase 3
- Stem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersStatus unknownNCT00740467Phase 2
- Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive ChemotherapyCompletedNCT00739388Phase 2
- Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantTerminatedNCT00725062Phase 1
- Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED)CompletedNCT00724789
- Decitabine and Bortezomib in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00703300Phase 1
- Pregnancy & Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 (Study 38827)(P06056)(COMPLETED)CompletedNCT00702988
- Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED)CompletedNCT00702195
- Total Marrow Irradiation for Refractory Acute LeukemiaCompletedNCT00686556Phase 1
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT00651716
- Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic SyndromesCompletedNCT00641030Phase 1
- Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological CancerCompletedNCT00627666Phase 2
- Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromesCompletedNCT00624936Phase 1
- Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced LeukemiaTerminatedNCT00618696Phase 1
- Exenatide Pregnancy Registry - Type 2 Diabetes in PregnancyTerminatedNCT00579150
- Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantCompletedNCT00569283Phase 1
- Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing ChemotherapyCompletedNCT00554489Not applicable
- Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid LeukemiaStatus unknownNCT00544999Phase 1
- Natural Killer Cells in Older Patients With Acute Myeloid LeukemiaCompletedNCT00540956Not applicable
- Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseCompletedNCT00521430Not applicable
- Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT00516828Phase 1/2
- RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI StudiesCompletedNCT00515359Not applicable
- Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyCompletedNCT00509691Phase 1
- Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00499785
- Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic LeukemiaCompletedNCT00499759Not applicable
- Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00489203Phase 2
- Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT00470197Phase 1
- Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell TransplantTerminatedNCT00469820Phase 1